Holton v. Physician Oncology Services

742 S.E.2d 702, 2013 Fulton County D. Rep. 1454, 292 Ga. 864, 37 I.E.R. Cas. (BNA) 390, 2013 WL 1859294, 2013 Ga. LEXIS 414, 107 U.S.P.Q. 2d (BNA) 2065
CourtSupreme Court of Georgia
DecidedMay 6, 2013
DocketS13A0012
StatusPublished
Cited by27 cases

This text of 742 S.E.2d 702 (Holton v. Physician Oncology Services) is published on Counsel Stack Legal Research, covering Supreme Court of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Holton v. Physician Oncology Services, 742 S.E.2d 702, 2013 Fulton County D. Rep. 1454, 292 Ga. 864, 37 I.E.R. Cas. (BNA) 390, 2013 WL 1859294, 2013 Ga. LEXIS 414, 107 U.S.P.Q. 2d (BNA) 2065 (Ga. 2013).

Opinion

Hunstein, Chief Justice.

In this case involving restrictive covenants in an employment agreement, Michael Holton appeals from the grant of an interlocutory injunction prohibiting him from working in an executive capacity for a particular competitor of his former employer for one year. He also challenges the trial court’s ruling that he would inevitably disclose his former employer’s trade secrets and confidential information in violation of the Trade Secrets Act and his confidentiality covenant if he went to work for the competing business. Because a stand-alone claim for the inevitable disclosure doctrine of trade secrets — untethered from the provisions of our state trade secret statute —• is not cognizable in Georgia, we reverse the part of the order enjoining Holton from the inevitable disclosure and use of trade secrets. On the remaining issues, we dismiss as moot his challenge to the order enjoining him from working for the competitor until October 2012 and affirm the part of the order enforcing the confidentiality covenant.

Holton was hired in August 2009 as the vice president and chief operating officer of Physician Oncology Services, LP, which provides radiation therapy services to cancer patients. In that position and later as president, Holton was responsible for overseeing the operations of seven facilities then operating in the metro Atlanta area. As part of the hiring process, Holton executed an employment agreement that contained a one-year noncompete covenant in which he agreed not to provide similar services to a competing business within a 25-mile radius of the seven company locations. The agreement also had a two-year confidentiality covenant in which he agreed not to use, divulge, disclose, or make accessible any confidential or proprietary information of the business or any personal information, which is defined as “any information concerning the personal, social, or business activities of its officers, directors, principals, partners, shareholders, agents, and employees.”

[865]*865In January 2011, Physician Oncology Services merged with Vantage Oncology, LLC, which operates 45 radiation oncology treatment centers in 12 states, including five in the Atlanta area. Following the merger, Holton continued to have oversight responsibilities for the operational facilities in Georgia and was the senior executive in charge of a project to integrate the two companies. In late May, Holton was removed from direct supervision of the day-to-day operations in Atlanta and became responsible for facilities in other states. On October 4, 2011, Vantage terminated Holton without cause, effective immediately.

A month later, Holton accepted employment with Ambulatory Services of America, Inc., to become the chief executive officer of its radiation oncology business, Radiation Oncology Services of America, Inc. (ROSA). ROSA is a competitor of Vantage and had four operating centers within the noncompete territory in Holton’s employment agreement, none of which were to fall within Holton’s day-to-day oversight. Vantage immediately sought a temporary restraining order and then an interlocutory injunction, alleging that Holton had violated his noncompete and confidentiality covenants, misappropriated trade secrets in violation of the Georgia Trade Secrets Act of 1990, and would inevitably disclose and use Vantage’s trade secrets. Vantage sought an injunction to prevent Holton from working for ROSA, which the trial court granted. The trial court found that Holton had knowledge of the following trade secrets and confidential information: a company initiative on a new technology measuring radiation doses, a project to improve business and management processes, the details of a direct-to-patient marketing plan, the markets and physicians’ practices targeted by Vantage for development or acquisition, and the company’s “practice models.” The trial court’s order enjoined Holton from (1) working for ROSA in any executive capacity from “the date of this Order through October 4, 2012,” (2) providing services that are substantially similar to the duties he performed for Vantage to any other competing business within a 25-mile radius of seven locations in metro Atlanta through October 4, 2012, and (3) using or disclosing confidential information or personal information that are trade secrets in perpetuity and those that do not qualify as trade secrets through October 4, 2013. Holton sought a stay of the injunction, which was denied. He appealed to the Court of Appeals, which transferred the case to this Court on the grounds that the appeal involves the legality and propriety of equitable relief. See Lee v. Environmental Pest & Termite Control, Inc., 271 Ga. 371 (1) (516 SE2d 76) (1999). Holton did not file a motion for supersedeas in this Court to try to prevent the appeal from becoming moot.

[866]*8661. Holton first challenges the trial court’s ruling that Vantage was likely to succeed on its claim that the noncompete covenant was valid under Georgia law and Holton’s employment with ROSA would constitute a breach of that covenant. Since October 4, 2012, when his noncompete covenant expired, Holton has been working as ROSA’s chief executive officer. At oral argument, Vantage acknowledged that it did not view Holton as violating the noncompete covenant as long as he abided by the confidentiality covenant. Because the injunction related to the one-year covenant not to compete has ended, we dismiss the appeal from that portion of the trial court’s order as moot. See Kellam v. Guthman Laundry and Dry Cleaning Co., 147 Ga. 133 (92 SE 872) (1917) (question whether employer properly granted injunction became moot after time expired for enforcing terms of order).

2. Holton next challenges the trial court’s ruling that Vantage was likely to prevail on the merits of its claim for the inevitable disclosure of trade secrets because Georgia has not adopted the inevitable disclosure doctrine and there is no evidence he has any Vantage documents or recalls any of its trade secrets. In its complaint, Vantage alleged as a separate claim that Holton “would inevitably misappropriate, disclose, and misuse” Vantage’s trade secrets and other confidential information in violation of the state trade secrets law and his employment agreement and sought to enjoin him from serving in an executive capacity for ROSAfor at least 12 months. Ruling in Vantage’s favor, the trial court determined that there was a substantial likelihood that Vantage would prevail on the merits of its claim that Holton, if employed by ROSA, “would inevitably disclose the confidential information and trade secrets of Plaintiffs.”

The purpose of an interlocutory injunction is “to maintain the status quo pending a final adjudication on the merits of the case.” Hampton Island Founders v. Liberty Capital, 283 Ga. 289, 293 (1) (a) (658 SE2d 619) (2008). A trial court has broad discretion in deciding whether to grant an interlocutory injunction. Byelick v. Michel Her-belin USA, 275 Ga. 505 (1) (570 SE2d 307) (2002); OCGA § 9-5-8. Among the factors it considers are whether: [867]*867SRB Investment Services, LLLP v. Branch Banking and Trust Co., 289 Ga. 1, 5 (3) (709 SE2d 267) (2011) (citation omitted). The trial court’s decision will not be reversed on appeal “unless the trial court made an error of law that contributed to the decision, there was no evidence on an element essential to relief, or the court manifestly abused its discretion.” Id. (citation and punctuation omitted); see also

Free access — add to your briefcase to read the full text and ask questions with AI

Related

MOTORSPORTS OF CONYERS, LLC v. EDMUND BURBACH
Court of Appeals of Georgia, 2026
NORTH AMERICAN SENIOR BENEFITS, LLC v. WIMMER
906 S.E.2d 373 (Supreme Court of Georgia, 2024)
Cotiviti, Inc. v. Deagle
S.D. New York, 2020
Fortress Investment Group, LLC v. Joel Holsinger
Court of Appeals of Georgia, 2020
Medical Center of Central Georgia, Inc. v. MacOn Health Center, Inc.
815 S.E.2d 199 (Court of Appeals of Georgia, 2018)
Cmgrp, Inc. v. Maggie Gallant
806 S.E.2d 16 (Court of Appeals of Georgia, 2017)
TMX Finance Holdings, Inc. v. Drummond Financial Services, LLC
797 S.E.2d 842 (Supreme Court of Georgia, 2017)
Mahalo Investments III, LLC v. First Citizens Bank & Trust Company, Inc.
769 S.E.2d 154 (Court of Appeals of Georgia, 2015)
India-American Cultural Association, Inc v. Ilink Professionals, Inc.
769 S.E.2d 905 (Supreme Court of Georgia, 2015)
Ryanne Early v. Mimedx Group, Inc.
768 S.E.2d 823 (Court of Appeals of Georgia, 2015)
State v. Walker
764 S.E.2d 804 (Supreme Court of Georgia, 2014)
VULCAN STEEL STRUCTURES, INC. Et Al. v. McCARTY Et Al.
764 S.E.2d 458 (Court of Appeals of Georgia, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
742 S.E.2d 702, 2013 Fulton County D. Rep. 1454, 292 Ga. 864, 37 I.E.R. Cas. (BNA) 390, 2013 WL 1859294, 2013 Ga. LEXIS 414, 107 U.S.P.Q. 2d (BNA) 2065, Counsel Stack Legal Research, https://law.counselstack.com/opinion/holton-v-physician-oncology-services-ga-2013.